Platelet activating factor induces transformation of human fibroblasts.
Bennett
S A
SA
Department of Biochemistry, University of Ottawa, Ont., Canada.
Birnboim
H C
HC
D000470:Alkaloids / Q000494:pharmacology; D000704:Analysis of Variance; D002455:Cell Division / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D019833:Genistein; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007231:Infant, Newborn; D007529:Isoflavones / Q000494:pharmacology; D010742:Phospholipid Ethers / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D012867:Skin; D019311:Staurosporine
D000470:Alkaloids; D006131:Growth Inhibitors; D007529:Isoflavones; D010742:Phospholipid Ethers; D010972:Platelet Activating Factor; C037913:CV 3988; D019833:Genistein; D011493:Protein Kinase C; D019311:Staurosporine; D007213:Indomethacin